威尔药业 (603351)

Nanjing Well Pharmaceutical Group Co., Ltd.

ASH

Tags

Innovative DrugsChemical PharmaceuticalsPharmaceuticals and HealthcarePetroleumHigh-Performing StocksShareholder Reduction

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 13543.91
  • Circulating A-Shares(W): 13543.91
  • Earnings Per Share(RMB): 0.8400
  • Net Assets Per Share(RMB): 12.9882
  • Operating Revenue(W RMB): 101824.17
  • Total Profit(W RMB): 13357.95
  • **Net Profit Attributable to Parent(W RMB) **: 11406.54
  • Net Profit Growth Rate(%): 1.03
  • Weighted Return on Equity(%): 6.5500
  • Operating Cash Flow Per Share(RMB): 1.0620
  • Undistributed Profit Per Share(RMB): 4.5451
  • Capital Reserve Per Share(RMB): 6.9390

2. Main Business

The main business covers:

  • Research, production, and sales of pharmaceutical excipients
  • Research, production, and sales of synthetic lubricant base oil products

3. Company Basic Information

  • Company Name: Nanjing Well Pharmaceutical Group Co., Ltd.
  • Listing Date: 2019-01-30
  • Industry: Pharmaceuticals and Healthcare - Chemical Pharmaceuticals (Tongdaxin Research Industry); Petroleum, Coal and Other Fuel Processing Industries (CSRC Industry)
  • Address: No. 99 Changfeng Hexi Road, Nanjing Chemical Industry Park, Jiangsu Province (Registered Address); Building 5, R&D Zone 5, Xuzhuang Software Park, No. 64 Suning Avenue, Xuanwu District, Nanjing City, Jiangsu Province (Office Address)
  • Website: https://www.wellnj.com/
  • Company Profile: The company was established through the overall change of Well Co., Ltd. On March 7, 2017, Well Co., Ltd. held a shareholders' meeting and resolved to change Well Co., Ltd. into a joint stock company. On March 7, 2017, 14 shareholders of Well Co., Ltd. signed the sponsor agreement. On March 25, 2017, the 14 shareholders of Well Co., Ltd. held the founding meeting of the joint stock company, agreeing to convert the audited net assets as of November 30, 2016 into shares, and overall change to establish Nanjing Well Pharmaceutical Co., Ltd. After the change, the registered capital was 50 million yuan, and the rest was included in the capital reserve. ShineWing Certified Public Accountants issued the "Capital Verification Report" (XYZH/2017NJA10111) on March 25, 2017. On April 19, 2017, the Nanjing Administration for Industry and Commerce issued the "Business License" for this change, with the legal representative being Wu Renrong.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Nanjing Shuntai Zonghua Venture Capital Partnership (Limited Partnership) Corporate Legal Person 934.93 6.90
2 China Universal Asset Management Co., Ltd. - National Social Security Fund 2103 Portfolio Social Security Fund 418.64 3.09
3 China Universal Jiatai Equity Special Pension Product - China Merchants Bank Co., Ltd. Asset Management Plan 293.38 2.17

5. Concept Sectors

  • Innovative Drugs
  • High-Performance Stocks
  • Shareholder Reduction

Remarks

  • Data update date: 2025-10-31
  • Data source: Public Market Information